NCT03057067

Brief Summary

Results of recent systematic reviews suggest favorable results of embolization for the treatment of Pelvic Congestion Syndrome (PCS) compared with pre-procedure symptoms for several outcomes, including pain reduction, overall patient satisfaction, and technical feasibility. Reported complication rates appears relatively low. Pelvic vein embolization is a relatively new technology and the results may provide background for an evidence based decision to offer embolization of pelvic varicosities for women with PCS in Norway.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 17, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

May 19, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 7, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 7, 2019

Completed
Last Updated

February 8, 2019

Status Verified

February 1, 2019

Enrollment Period

1.7 years

First QC Date

February 15, 2017

Last Update Submit

February 7, 2019

Conditions

Keywords

Embolization, TherapeuticPelvis

Outcome Measures

Primary Outcomes (3)

  • chronic pelvic pain

    assessed by a numeric rating scale (0-10) within the questionnaire of the Norwegian Society for Pain

    3 months

  • chronic pelvic pain

    assessed by a numeric rating scale (0-10) within the questionnaire of the Norwegian Society for Pain

    6 months

  • chronic pelvic pain

    assessed by a numeric rating scale (0-10) within the questionnaire of the Norwegian Society for Pain

    1 year

Secondary Outcomes (6)

  • Health related quality of life (HRQOL)

    3 months

  • Health related quality of life (HRQOL)

    6 months

  • Health related quality of life (HRQOL)

    1 year

  • Sexual function

    3 months

  • Sexual function

    6 months

  • +1 more secondary outcomes

Study Arms (1)

pelvic vein embolization

EXPERIMENTAL

female patients referred for assessment of chronic pelvic pain at the gynecological outpatient clinic or the Multidisciplinary Pain Clinic at St. Olavs Hospital, Trondheim, Norway

Procedure: Embolization of pelvic vein varicosities

Interventions

Embolization of pelvic vein varicosities

pelvic vein embolization

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pelvic pain (lasting for more than 6 months)
  • Symptoms of PCS - deterioration of pain when standing and improvement in supine position (with or without dyspareunia or dysmenorrhea).
  • Confirmed pelvic varicosities by magnetic resonance examination.
  • Signed, written and informed consent

You may not qualify if:

  • Inability to communicate in Norwegian
  • Known endometriosis
  • Uterine myoma, uterine anomalies, or cancer
  • Postmenopausal
  • not having been pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Olavs Hospital

Trondheim, Norway

Location

MeSH Terms

Conditions

Pelvic PainVaricose Veins

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsVascular DiseasesCardiovascular Diseases

Study Officials

  • Risa AM Lonnee-Hoffmann, md phd

    St. Olavs Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All female patients referred for assessment of chronic pelvic pain at the gynecological outpatient clinic or the Multidisciplinary Pain Clinic at St. Olavs Hospital are eligible for initial assessment
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 15, 2017

First Posted

February 17, 2017

Study Start

May 19, 2017

Primary Completion

February 7, 2019

Study Completion

February 7, 2019

Last Updated

February 8, 2019

Record last verified: 2019-02

Locations